牛凝血酶, 低比活性, 新西兰源,Thrombin, bovine, low specific activity

Name: 牛凝血酶, 低比活性, 新西兰源,Thrombin, bovine, low specific activity
SKU: 02199907-CF

CN¥0.00

Key features and details

新西兰原产，符合ISO质量认证体系及cGMP规范，使用先进的设备采用色谱层析法制备

SKU: 02199907-CF

Synonyms

Factor IIa; Thrombin from bovine plasma

CAS Number:

9002-04-4

EC Number:

232-648-7

Request A Custom or Bulk Quote

Product Description

凝血酶广泛应用于诊断行业中，用于凝血实验，凝血因子测试以及全血或血浆的去纤维化以用于血清的对照实验。凝血酶还可用于重组融合蛋白的特异性位点酶切等生化实验中。
低比活性的牛凝血酶以新西兰源牛血浆为原料制备凝血酶原，使用从新西兰源的牛肺组织中提取的凝血活酶激活凝血酶原，通过分离纯化获得，并在真空下冷冻干燥以粉末的形式供应。低比活力凝血酶的比活力为90-300 NIH U/mg蛋白，总蛋白含量大于50%。

Application Notes

凝血酶广泛应用于诊断行业中，用于凝血实验，凝血因子测试以及全血或血浆的去纤维化以用于血清的对照实验。凝血酶还可用于重组融合蛋白的特异性位点切割等生化实验中。低比活性的牛凝血酶以新西兰源牛血浆为原料制备凝血酶原，使用从新西兰源的牛肺组织中提取的凝血活酶激活凝血酶原，通过分离纯化获得，并在真空下冷冻干燥以粉末的形式供应。低比活力凝血酶的比活力为90-300 NIH U/mg蛋白，总蛋白含量大于50%。凝血酶已用于评估感染性休克患者持续性低凝状态的研究。

Usage Statement

Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department.

Specifications

SKU	02199907-CF
Alternate Names	Factor IIa; Thrombin from bovine plasma
Application Notes	凝血酶广泛应用于诊断行业中，用于凝血实验，凝血因子测试以及全血或血浆的去纤维化以用于血清的对照实验。凝血酶还可用于重组融合蛋白的特异性位点切割等生化实验中。低比活性的牛凝血酶以新西兰源牛血浆为原料制备凝血酶原，使用从新西兰源的牛肺组织中提取的凝血活酶激活凝血酶原，通过分离纯化获得，并在真空下冷冻干燥以粉末的形式供应。低比活力凝血酶的比活力为90-300 NIH U/mg蛋白，总蛋白含量大于50%。凝血酶已用于评估感染性休克患者持续性低凝状态的研究。
Base Catalog Number	199907
Biochemical Physiological Actions	Serine protease that selectively cleaves Arg-Gly bonds in fibrinogen to form fibrin and fibrinopeptides A and B.
CAS #	9002-04-4
EC Number	232-648-7
Extinction Coefficient	E<sub>280</sub><sup>1%</sup> = 18.3 (human); E<sub>280</sub><sup>1%</sup> = 19.5 (bovine)
Format	Lyophilized powder
Grade	Analytical Grade
Hazard Statements	H315-H319-H334-H335
Host	Bovine
pH	7.0 - 8.0
Protein or Enzyme Type	Plasma & Blood Proteins
RTECS Number	XO8950000
Safety Symbol	GHS07, GHS08
Specific Activity	90 - 300 u/mg protein
Unit Definition	Activity is expressed in NIH units obtained by direct comparison to a NIH Thrombin Reference Standard, Lot K. The NIH assay procedure uses 0.2 mL of diluted plasma (1:1 with saline) as a substrate and 0.1 mL of albumin solution based on a modification of the method of Biggs. Only clotting times in the range of 15–25 seconds are used for determining thrombin activity. Optimal clotting temperature is 37 °C.
Usage Statement	Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department.